En clinical Glorieta They have taken a further step towards modernization and innovation, now incorporating their new Sleep Unit. This new feature will strengthen the patient's care and also have a treatment without hospital admission.
The supervised polygraphs are sleep tests where snoring, thoracic and abdominal movement, respiratory flow, heart rate and saturation are recorded, and CPAP (continuous positive airway pressure, according to the acronym in English) titrations with autoCPAP. Likewise, by having this unit, educational activities will be carried out aimed at patients undergoing treatment with CPAP.
The Head of this Unit, the Doctor and cardiologist Fernando de la Guían indicates that sleep apnea is a very prevalent disease in the population that can cause a significant deterioration in the quality of life, with high blood pressure, cardiovascular and cerebrovascular diseases, as well as as traffic accidents and is related to an excess of mortality.
In addition, the cardiologist clarifies that undiagnosed patients double the consumption of health resources with respect to those diagnosed and treated. In Spain between 3 and 6% of the population suffers from symptomatic sleep apnea-hypopnea syndrome (SAHS) and 25% have a highly altered apnea-hypopnea index (AHI> 54).
The doctor of the Guide points out that the main sectors of the population that tend to suffer more from sleep apnea, are the elderly, male and with a high body mass index (overweight or obese), in such a way, that the prevalence increases with age reaching triple in the elderly compared to middle ages. It can also be related to the habitual drinking of alcohol, tobacco, sedatives, hypnotics and the face-up position.
In addition, Glorieta Clinic will have a modern domiciliary respiratory polygraphy, without the need of hospital admission, which the patient can take home and sleep comfortably with her. Being a record no less than 6,5 hours and must include at least 3 hours of sleep.
In short, it is an acceptable method to confirm the diagnosis of patients with clinical suspicion of moderate or high sleep apnea-hypopnea syndrome.
